Trial
NCT00004239
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI)
Condition
Chronic Myeloproliferative Disorders
Intervention
Compound 506U78
Why stopped
poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-04